SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001424884-17-000028
Filing Date
2017-04-14
Accepted
2017-04-14 14:13:56
Documents
3
Period of Report
2017-02-28

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ON FORM 10-Q qbio_10q.htm 10-Q 454907
2 CEO CERTIFICATE UNDER SECTION 302 ceo_cert_1.htm EX-31.1 14374
3 CEO CERTIFICATE UNDER SECTION 1350 ceo_cert_2.htm EX-32.1 5774
  Complete submission text file 0001424884-17-000028.txt   476161
Mailing Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022
Business Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-55535 | Film No.: 17762694
SIC: 2834 Pharmaceutical Preparations